New AAP Guidance: Exome and genome sequencing recommended as first-line tests. Learn more

Let’s talk about the latest discoveries in person

Join us for our presentation or set up one-on-one time with someone from our team.

Learn more about our latest updates & news

Read our blog

Don’t miss our presentation

Quantifying Rare: A Data-Driven Approach to Monogenic Disorder Prevalence 

Calendar icon June 24, 4:55 pm
Location icon Innovation Stage

 

This presentation will cover: 

  • How cohort selection impacts observed prevalence of monogenic disorders
  • Why real-world genomic data is critical to overcoming ascertainment bias
  • How large-scale exome/genome datasets can improve disease modeling and target validation
  • Real examples of using diverse genetic and clinical data to refine prevalence estimates

Meet the speakers

Photo of
Logo

Mahmoud Husseini

Head of Biopharma at GeneDx, leads initiatives that integrate genomic data into drug discovery and development. Under his leadership, GeneDx has launched tools like Discover to leverage an industry-leading dataset that contributes to the advancement of targeted therapies, particularly for rare genetic disorders.

Photo of
Logo

Sun-Gou Ji

Vice President, Head of Computational Genetics at BridgeBio, leads a team that uses large datasets and computational tools to support decision making across early discovery research and late-stage clinical programs.